Though Thermo Fisher just completed a $10.6 billion merger creating a life sciences behemoth, the firm’s CEO said last week that he sees plenty of opportunities to continue growing the firm through acquisitions.
The comments from Marijn Dekkers came one day before the firm bought Cohesive Technologies, a small acquisition that it believes will beef up its sample-preparation offerings for its liquid chromatography and mass spectrometry products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.